China NMPA Approves Xeligekimab Injection for the Treatment of Plaque Psoriasis
π© info@dengyuemed.com
πhttps://dengyuemed.com
#DrugApproval #Psoriasis #IL17A #Biologics #ChinaPharma #DengYueMedicine
China NMPA Conditionally Approves Golixitinib Capsules for Market
π© info@dengyuemed.com
πhttps://dengyuemed.com
#ChinaPharma #OncologyInnovation #Golixitinib #PTCL #Dizal #NMPA #DengYueMedicine #PharmaceuticalExports #JAKInhibitor #ChineseInnovativeDrugs
Chinaβs Pharma Exports: A New Global Chapter in Healthcare Trade
π© info@dengyuemed.com
πhttps://dengyuemed.com/
#PharmaceuticalExports #ChinaPharma #GlobalHealthcare #Innovation #Trade #HongKong #LifeSciences #PharmaIndustry #HealthcareInnovation #DengYueMedicine
From Hong Kong to the World: How DengYue Medicine Bridges Chinaβs Innovative Pharma
π© info@dengyuemed.com
πhttps://dengyuemed.com/
#ChinaPharma #GlobalHealth #DengYueMedicine #HongKongPharma #InnovativeDrugs #PharmaExport #ClinicalTrials #OncologyCare #ChinaInnovation #PharmaLogistics